A phase III, double-blind, non-inferiority, randomized controlled trial of antiemetic prophylaxis for highly emetogenic chemotherapy without dexamethasone: CINV POD study

被引：0
|
作者：
Radhakrishnan, Venkatraman [1 ]
Venkatakrishnan, Kritthivasan [1 ]
Kalaiyarasi, Jayachandran Perumal [1 ]
Selvarajan, Gangothri [1 ]
Mahaboobasha, Nizamudin [1 ]
Victor, Paulson Vijaykumar [1 ]
Anbazhagan, Malarvizhi [1 ]
Sivanandam, Deyva Manohari [1 ]
Rajaraman, Swaminathan [1 ]
机构：
[1] Canc Inst WIA, Chennai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12127
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)
    Radhakrishnan, Venkatraman
    Venkatakrishnan, Kritthivasan
    Kalaiyarasi, Jayachandran Perumal
    Selvarajan, Gangothri
    Mahaboobasha, Nizamudin
    Victor, Paulson Vijaykumar
    Anbazhagan, Malarvizhi
    Sivanandam, Deyva Manohari
    Rajaraman, Swaminathan
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [2] A DOUBLE-BLIND, NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL OF TRANSVAGINAL PROCEDURES FOR THE REPAIR OF A RECTOCELE
    Henn, E. W.
    Richter, B. W.
    Burger, D. A.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 : S31 - S32
  • [3] ANTIEMETIC EFFICACY OF CIMETIDINE RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY WITH DEXAMETHASONE IN CANCER-PATIENTS RECEIVING EMETOGENIC CHEMOTHERAPY
    ALGHAMDI, MS
    IBRAHIM, EM
    ALIDRISSI, HY
    ALKHATTI, AA
    ALFARAJ, A
    ANNALS OF ONCOLOGY, 1991, 2 (07) : 517 - 518
  • [4] Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial
    Rhee, Chin Kook
    Chang, Jung Hyun
    Choi, Eu Gene
    Kim, Hyun Kuk
    Kwon, Yong-Soo
    Kyung, Sun Young
    Lee, Ji-Hyun
    Park, Myung Jae
    Yoo, Kwang Ha
    Oh, Yeon Mok
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2265 - 2275
  • [5] Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
    Javaud, Nicolas
    Soria, Angele
    Maignan, Maxime
    Martin, Ludovic
    Descamps, Vincent
    Fain, Olivier
    Bouillet, Laurence
    Berard, Frederic
    Tazarourte, Karim
    Roy, Pierre-Marie
    Fontaine, Jean-Paul
    Bagot, Martine
    Khellaf, Mehdi
    Goulet, Helene
    Lapostolle, Frederic
    Casalino, Enrique
    Doutre, Marie-Sylvie
    Gil-Jardine, Cedric
    Caux, Frederic
    Chosidow, Olivier
    Pateron, Dominique
    Vicaut, Eric
    Adnet, Frederic
    BMJ OPEN, 2019, 9 (08):
  • [6] Olanzapine, an alternative to dexamethasone for preventing nausea and vomiting induced by cisplatin-based doublet highly emetogenic chemotherapy: A non-inferiority, prospective, multi-centered, randomized, controlled, phase III clinical trial
    Liu, Z.
    Zhou, Y.
    Feng, W-N.
    Chen, M-Y.
    Han, G.
    Zou, G-R.
    Yang, S.
    He, Y.
    Zou, X.
    Tang, J.
    Zhang, L.
    Cui, L.
    Chen, H.
    Li, G.
    Jiang, S.
    Gao, J.
    Xiao, L.
    Zhang, Q.
    Yi, W.
    Huang, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1340 - S1340
  • [7] Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial
    Lee, Christine H.
    Patino, Hernando
    Stevens, Chris
    Rege, Shruta
    Chesnel, Laurent
    Louie, Thomas
    Mullane, Kathleen M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (10) : 2964 - 2971
  • [8] Efficacy and Safety of Olanzapine in Children Receiving Highly Emetogenic Chemotherapy: A Randomized, Double-blind Placebo-controlled Phase 3 Trial
    Moothedath, Abdul W.
    Meena, Jagdish P.
    Gupta, Aditya K.
    Velpandian, Thirumurthy
    Pandey, Ravindra M.
    Seth, Rachna
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (08) : 446 - 453
  • [9] Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
    Navari, Rudolph M.
    Le-Rademacher, Jennifer
    Smieliauskas, Fabrice
    Ruddy, Kathryn J.
    James Saphner, Thomas
    Liu, Heshan
    Harlos, Elizabeth
    Onitilo, Adedayo A.
    Giridhar, Karthik
    Paul Singh, Preet
    Reddy, Pavan S.
    Chow, Selina
    Kruter, Flavio
    Raptis, George
    Loprinzi, Charles L.
    ONCOLOGIST, 2023, : 722 - 729
  • [10] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
12345